Sign Up to Receive Your Personalised Learning Resources
JOURNALS
SARS-CoV-2 mRNA vaccination associated with increased survival in patients with lung cancer and melanoma treated with immune checkpoint inhibitors
Start Learning
Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management
Durvalumab with neoadjuvant chemotherapy and radical cystectomy in muscle-invasive bladder cancer
Current treatments and unmet needs in limited-stage small cell lung cancer
Expanding HER2 horizons: Implications for NSCLC and beyond
Addition of nivolumab to rucaparib did not improve clinical outcomes in newly diagnosed, advanced, high-grade ovarian cancer
Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma: From optimal sequencing to shared decision-making
Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024
Greatest hits of 2024
Project Cure CRC pushes for cutting-edge innovations in colorectal cancer care
Where to next in limited-stage small cell lung cancer? The role of immune checkpoint inhibitors
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
What’s on the horizon to tackle unmet needs in recurrent/metastatic SCCHN?
View
Is HER2 targeting on the horizon in urothelial carcinoma?
View
Advancing the treatment of muscle-invasive bladder cancer: Updates on immunotherapy in the perioperative setting
View
Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma: From optimal sequencing to shared decision-making
View
Nivolumab plus Relatlimab alongside chemotherapy demonstrated improved clinical benefit in the RELATIVITY-104 trial
View
Tools to guide treatment decisions in early breast cancer: Genomic testing and emerging role of MRD
View
Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life
View
Expanding HER2 horizons: Implications for NSCLC and beyond
View
A New Frontier in the Treatment of Epidermal Growth Factor Receptor-mutated Non–Small-Cell Lung Cancer: Amivantamab-vmjw and Chemotherapy
View
Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies
View
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
